(Q45192002)

English

Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial

scientific article published in January 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 December 2017

Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial (English)

1 reference

Europe PubMed Central

10 December 2017

0 references

type 2 diabetes

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Coenraad Dirk Adriaan Stehouwer

10

object named as

C D A Stehouwer

1 reference

Europe PubMed Central

10 December 2017

Casper G. Schalkwijk

8

object named as

C G Schalkwijk

1 reference

Europe PubMed Central

10 December 2017

author name string

J De Jager

1

1 reference

Europe PubMed Central

10 December 2017

A Kooy

2

1 reference

Europe PubMed Central

10 December 2017

Ph Lehert

3

1 reference

Europe PubMed Central

10 December 2017

D Bets

4

1 reference

Europe PubMed Central

10 December 2017

M G Wulffelé

5

1 reference

Europe PubMed Central

10 December 2017

T Teerlink

6

1 reference

Europe PubMed Central

10 December 2017

P G Scheffer

7

1 reference

Europe PubMed Central

10 December 2017

A J M Donker

9

1 reference

Europe PubMed Central

10 December 2017

language of work or name

0 references

publication date

1 January 2005

1 reference

Europe PubMed Central

10 December 2017

Journal of Internal Medicine

1 reference

Europe PubMed Central

10 December 2017

257

1 reference

Europe PubMed Central

10 December 2017

100-109

1 reference

Europe PubMed Central

10 December 2017

1

1 reference

Europe PubMed Central

10 December 2017

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01420.X

21 January 2018

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01420.X

21 January 2018

Improved endothelial function with metformin in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01420.X

21 January 2018

Effects of short‐term treatment with metformin on serum concentrations of homocysteine, folate and vitamin B12 in type 2 diabetes mellitus: a randomized, placebo‐controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01420.X

21 January 2018

Endothelial dysfunction and pathogenesis of diabetic angiopathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01420.X

21 January 2018

von Willebrand factor: a marker of endothelial damage?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01420.X

21 January 2018

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01420.X

21 January 2018

Poorly controlled elderly Type 2 diabetic patients: the effects of increasing sulphonylurea dosages or adding metformin.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01420.X

21 January 2018

Soluble cell adhesion molecules in hypertriglyceridemia and potential significance on monocyte adhesion

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01420.X

21 January 2018

Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01420.X

21 January 2018

The short-term effect of a switch from glibenclamide to metformin on blood pressure and microalbuminuria in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01420.X

21 January 2018

Metformin: intrinsic vasculoprotective properties

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01420.X

21 January 2018

Metformin: An Update

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01420.X

21 January 2018

Combined metformin-sulfonylurea treatment of patients with noninsulin-dependent diabetes in fair to poor glycemic control

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01420.X

21 January 2018

Effect of metformin on adipose tissue resistin expression in db/db mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01420.X

21 January 2018

Beneficial effects of metformin in normoglycemic morbidly obese adolescents

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01420.X

21 January 2018

Identifiers

10.1111/J.1365-2796.2004.01420.X

1 reference

Europe PubMed Central

10 December 2017

release_7z4cgvkwsneatefpdqnvqqhuti

1 reference

https://api.fatcat.wiki/v0/release/7z4cgvkwsneatefpdqnvqqhuti

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

10 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45192002&oldid=2069448574"